Drug Development

Articles

Also, Bristol-Myers Squibb forms collaboration with ZymoGenetics, Hana Biosciences appoints VP of regulatory affairs, more...

Company and People Notes: Ratiopharm Up for Sale; Sutro Biopharma Appoints CEO, More...

Also, Novozymes Biologicals settles pollution case with the US Department of Justice; EntreMed restructures management team; more...

Company and People Notes: Chiral Technologies Europe Acquires ChromTech; Pharmalot Blogger Ed Silverman Resigns; More...

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

Achieving double-digit growth through 2011, biotech-based active pharmaceutical ingredients (APIs) are expected to far surpass growth rates for chemically synthesized APIs.

Promising Outlook for Biotech APIs

Catalysis for olefin metathesis and aldol reactions and synthetic routes to natural products are some recent gains.

Optimizing Small-Molecule Synthesis

Michelle Hoffman, editorial director of Pharmaceutical Technology.

The incoming administration has renewed hope for stem cells, but less adequate copycats may follow.

A New Start for New Cells

Angie Drakulich was editorial director of Pharmaceutical Technology.

After a year of increased attention on the pharmaceutical supply chain in Asia, what will be the region's short- and long-term role? This article contains bonus online-exclusive material.

Evaluating the Pieces of the Pharma Supply Chain

Instead of hampering progress, cost pressures might inspire Big Pharma to get creative.

Will 2009 Bring Innovation?

A new excipient for orally disintegrating tablets not only imparts superior tablet characteristics, but has the added advantage of allowing users to maintain full control over their formulations, manufacturing processes and intellectual property.

Application-related properties of a new fast dispersible excipient

Also, Crucell and DSM announce deals with GSK, Talecris, and CSL; Nobel Prize winner Luc Montagnier joins Viral Genetics; more...

Company and People Notes: Abbott to Acquire Ibis Biosciences; Pfizer Appoints Senior VP of Litigation; More...

The US Food and Drug Administration issued a draft guidance, Genotoxic and Carcinogenic Impurities in Drug Substances and Products: Recommended Approaches.

Ingredients